Little House Capital’s Varian Medical Systems, Inc. VAR Stock Holding History

Little House Capital’s Portfolio VAR Stock Details VAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-100	Closed	-$14K	–	293
2019 Q1	$14K	Buy	+100	New	+$13.1K	0.01%	232

Other funds holding VAR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Little House Capital's VAR Position: Q2 2019 in Review

Little House Capital sold out of Varian Medical Systems, Inc. (VAR) in Q2 2019, closing a stake of 100 shares — an estimated $14K sold.

Little House Capital first reported a position in VAR in Q1 2019 and held it in 1 quarter. The position peaked at $14K in Q1 2019. 585 funds tracked by Wall St. Rank hold VAR as of Q2 2019.

Little House Capital reported no remaining Varian Medical Systems, Inc. position as of Q2 2019 after selling out during the quarter.
Little House Capital sold 100 Varian Medical Systems, Inc. shares in Q2 2019, an estimated $14K.
Little House Capital first reported a position in Varian Medical Systems, Inc. in Q1 2019 and held it in 1 quarter.
Little House Capital's Varian Medical Systems, Inc. position peaked at $14K in Q1 2019.
585 funds tracked by Wall St. Rank held Varian Medical Systems, Inc. as of Q2 2019.

Based on Little House Capital's 13F filing for Q2 2019, filed 14 Aug 2019.